Price $90.22 |
Market Cap
133.27B
|
Sector Health Care |
Div. Growth
6.10%
|
|
P/E
26.7
|
P/B
2.5
|
P/S
4.15
|
Dividend %
2.80%
|
|
P/CF
-
|
P/FCF
52.7
|
Op. Cash Flow
7.16M
|
FCF
1.8
|
|
Op. Margin
16.70%
|
Net Margin
14.80%
|
ROE
9.10%
|
ROI
4.90%
|
|
ROA
5.10%
|
EPS Growth
62.40%
|
Current Ratio
2.6
|
Debt/Equity
51.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Psychemedics Corp. (PMD) | $6.29 | - | 4.50% | 35.3M | Strong Buy |
| Clearside Biomedical Inc (CLSD) | $1.65 | - | - | 78.2M | Strong Buy |
| Repro-Med Systems, Inc. (KRMD) | $2.43 | - | - | 98.3M | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $0.65 | - | - | 22.7M | Strong Buy |
| Novo Integrated Sciences Inc (NVOS) | $1.91 | - | - | 61.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
